A detailed history of Quest Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quest Partners LLC holds 18,751 shares of BMY stock, worth $1.05 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
18,751
Previous 12,156 54.25%
Holding current value
$1.05 Million
Previous $629 Million 68.62%
% of portfolio
0.14%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$51.92 - $59.94 $342,412 - $395,304
6,595 Added 54.25%
18,751 $1.06 Billion
Q3 2024

Nov 07, 2024

SELL
$39.66 - $51.75 $1.14 Million - $1.49 Million
-28,722 Reduced 70.26%
12,156 $629 Million
Q2 2024

Aug 06, 2024

BUY
$40.25 - $52.99 $1.64 Million - $2.16 Million
40,742 Added 29957.35%
40,878 $1.7 Billion
Q1 2024

May 09, 2024

SELL
$47.98 - $54.4 $892,523 - $1.01 Million
-18,602 Reduced 99.27%
136 $7.38 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $908,418 - $1.08 Million
18,738 New
18,738 $961 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.